Physician profile
Maher Gobran
NPI 1740338557
$2,546.49
in general payments reported to CMS, 2019-2025
12 companies · $2,181 in 2025
The $2,181 reported for 2025 was more than what 83% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $35.88 · 2021: $52.60 · 2022: $61.10 · 2023: $176 · 2024: $39.67 · 2025: $2,181.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,480 · Food and Beverage: $917.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,480.04 |
| Food and Beverage | $916.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axogen | $2,129.49 | 2025 | |
| Sirius Medical Systems | $109.15 | 2023 | Pintuition |
| Davol INC. | $63.84 | 2019-2023 | Phasix Mesh |
| Biotissue Holdings INC. | $43.85 | 2022 | |
| Cardinal Health 414 LLC | $39.67 | 2024 | Kit For The Preparation of Lymphoseek (Technetium Tc 99m Tilmanocept) |
| Intuitive Surgical, INC. | $30.96 | 2021-2023 | Da Vinci Surgical System |
| Olympus America INC. | $27.78 | 2021 | |
| Medtronic, INC. | $26.76 | 2025 | Signia |
| Merit Medical Systems INC | $24.78 | 2025 | Savi Scout |
| Tela Bio, INC. | $19.98 | 2019 | |
| Musculoskeletal Transplant Foundation INC. | $17.25 | 2022 | |
| Integra Lifesciences Corporation | $12.98 | 2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maher Gobran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.